Search company, investor...

Acorda Therapeutics - Manufacturing and Packaging Operations

Stage

Acquired Unit | Acquired

About Acorda Therapeutics - Manufacturing and Packaging Operations

Acorda Therapeutics, a privately held biotechnology company, is developing therapies for spinal cord injury (SCI and related neurological conditions, including multiple sclerosis (MS. The Companyƒ-s lead product, Fampridine-SR, is in Phase 3 clinical trials for chronic SCI and Phase 2 for MS. Acordaƒ-s technology platform includes two remyelinating agents in preclinical development for MS. They include M1, a class of human monoclonal antibodies, and GGF2, a product of the neuregulin 1 gene. Both agents have been shown to restore myelin in the brain and spinal cord in animal models of MS. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain. In 2002, Acorda was the recipient of the National Spinal Cord Injury Associationƒ-s L. W. Freeman Award for scientific research. Nasdaq: ACOR

Headquarters Location

420 Saw Mill River Road

Ardsley, New York, 10502,

United States

914-347-4300

Missing: Acorda Therapeutics - Manufacturing and Packaging Operations's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Acorda Therapeutics - Manufacturing and Packaging Operations's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Acorda Therapeutics - Manufacturing and Packaging Operations Frequently Asked Questions (FAQ)

  • Where is Acorda Therapeutics - Manufacturing and Packaging Operations's headquarters?

    Acorda Therapeutics - Manufacturing and Packaging Operations's headquarters is located at 420 Saw Mill River Road, Ardsley.

  • What is Acorda Therapeutics - Manufacturing and Packaging Operations's latest funding round?

    Acorda Therapeutics - Manufacturing and Packaging Operations's latest funding round is Acquired Unit.

  • Who are the investors of Acorda Therapeutics - Manufacturing and Packaging Operations?

    Investors of Acorda Therapeutics - Manufacturing and Packaging Operations include Catalent.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.